Latest Regulatory Scrutiny News

QBE Insurance Group has priced a AUD 600 million subordinated notes issuance, strengthening its capital base under APRA regulations with notes maturing in 2036.

Mayne Pharma has voluntarily withdrawn a speaker presentation for its contraceptive NEXTSTELLIS® following an FDA Untitled Letter concerning promotional claims. The company confirms this does not impact sales or its planned merger with Cosette.

An application to the Takeovers Panel challenges Pact Group Holdings’ planned ASX delisting, citing concerns over shareholder disadvantage and selective disclosure.

Macquarie Bank Limited reported an 18% rise in net profit for FY2025, driven by growth in its retail banking segment despite margin pressures, while its commodities business faced subdued markets. The bank maintained strong capital ratios and advanced its risk and technology frameworks amid regulatory scrutiny.

Macquarie Group reported a 5% rise in full-year net profit to A$3.715 billion for FY25, driven by growth across its diversified businesses and a solid capital position. The group’s assets under management reached A$941 billion, supported by strong home loan and deposit growth.

Macquarie Group Limited has posted a 5% increase in net profit for FY2025, driven by strong asset management and banking growth, while advancing its sustainability and digital innovation agenda.

AF Legal Group has resolved a significant legal claim related to a senior lawyer's 2022 hire, incurring up to $600,000 in costs, while navigating an ongoing regulatory probe. Despite these challenges, the firm remains optimistic about improved profitability in the second half of FY25.

ANZ Group Holdings Limited delivered its strongest half-year revenue and profit to date, buoyed by the full contribution from Suncorp Bank and a robust capital position despite regulatory challenges.

Tivan Limited has responded to ASX inquiries about a social media post by its executive chair concerning fluorite exploration, affirming compliance with disclosure rules and pending assay results.

National Australia Bank has reported robust half-year results with cash earnings of $3.58 billion and announced a fully franked interim dividend of 85 cents per share, underscoring its strong market position and strategic clarity.

Pancontinental Energy has responded to an ASX query about recent spikes in its share price and trading volume, confirming no undisclosed information exists and pointing to strong industry interest in its PEL 87 project.

Citigold Corporation Limited has faced intense ASX scrutiny following an adverse auditor opinion on its half-year financials, centering on a $20 million impairment of exploration assets. The company defends its valuation approach despite funding uncertainties and regulatory questions.